Media Highlights

Identifying Patients At Risk of Severe Complications Using Sequencing Technology

Identifying Patients At Risk of Severe Complications Using Sequencing Technology

Dr. Bob Hancock, UBC Killam professor, will use genomic methods to identify which patients with COVID-19 are at higher risk of developing life-threatening sepsis.

Anticoagulant RNA-Based Therapies For SARS-CoV-2 Related Thrombosis

Anticoagulant RNA-Based Therapies For SARS-CoV-2 Related Thrombosis

SARS-CoV-2 leads to hyper-coagulability of blood and deadly blood clots (thrombosis).

Risk Management Frameworks For Workplace Safety

Risk Management Frameworks For Workplace Safety

As Canada and other countries develop strategies for economic recovery and returning to business, the challenge each government and business faces will be how to develop solutions that can mitigate COVID-19 spread and the risks to a safe return to places of employment.

Predicting the evolution of COVID-19 to help manage future outbreaks

Predicting the evolution of COVID-19 to help manage future outbreaks

As the world prepares for future waves of COVID-19, the ability to predict mutations in the novel coronavirus even before they emerge will be essential to stopping future outbreaks.

Host Cellular Protein Substrates Of SARS-COV-2 Proteases

Host Cellular Protein Substrates Of SARS-COV-2 Proteases

The recent outbreak of coronavirus SARS-CoV-2 (2019-2020) leading to COVID-19 disease in China and worldwide has led to increased urgency in identifying strategies to mitigate the spread of coronavirus infection and treat infected individuals.

Notes from the CBR Director

Notes from the CBR Director

When the Centre for Blood Research (CBR) team of editors and writers were compiling and laying all the fabulous stories, reports and photos for display in this issue of the CBR Magazine, the best parts of BC were revealing themselves.

Jobs in industry: a day in the life of a Medical Science Liaison

Jobs in industry: a day in the life of a Medical Science Liaison

In early November 2019, the Centre for Blood Research proudly presented ‘Breakfast with Bayer,’ a networking opportunity for trainees to meet with representatives from the life sciences company.

Inside the CBR and LSI – basic scientists, vendors and staff band together to support health care workers on the front lines of COVID-19

Inside the CBR and LSI – basic scientists, vendors and staff band together to support health care workers on the front lines of COVID-19

The past couple of weeks has seen most of us in the CBR and the LSI rapidly curtailing research activities.

New Automation Facility (B!) Opens in LSI

New Automation Facility (B!) Opens in LSI

In September 2019, the new Biofactorial (B!) automation and screening facility opened for business in UBC. Located on the second floor of the Life Sciences Institute (LSI), the facility aims to assist UBC researchers in automation and high-throughput biology applications to help reduce experimental costs and enhance the speed of research.

Hancock Lab Develops a New Tool for Studying Chlamydia Infection

Hancock Lab Develops a New Tool for Studying Chlamydia Infection

While the pathological findings of the study will indeed be beneficial to antibiotic development, it is the innovative approach used in creating the in vitro model that must be highlighted.